Minerva Neurosciences (NERV) Cash & Equivalents (2013 - 2026)
Minerva Neurosciences' Cash & Equivalents was $24.65 million in Q2 2026, up 61.7% from $15.25 million a year earlier but down 24.5% from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Minerva Neurosciences came in at $82.3 million, up 285.3% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $21.36 million in FY2024 (-47.8%), $40.91 million in FY2023 (+13.4%), $36.09 million in FY2022 (-40.6%) and $60.76 million in FY2021 (+139.6%).
- Quarterly Cash & Equivalents has moved between $12.29 million (Q3 2025) and $82.3 million (Q4 2025) over five years.
- Compared with a year earlier, Cash & Equivalents has increased for three straight quarters, with growth averaging 23.7% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2025 (growth of 285.3%); the worst was Q3 2025 (a decline of 53.7%).
- Per Business Quant data, NERV's Cash & Equivalents in the three quarters before Q2 2026 was $32.66 million (Q1 2026), $82.3 million (Q4 2025) and $12.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Minerva Neurosciences | 154.91 Mn | 154.91 Mn | - | 24.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.65 Mn |
| Mar 31, 2026 | 32.66 Mn |
| Dec 31, 2025 | 82.30 Mn |
| Sep 30, 2025 | 12.29 Mn |
| Jun 30, 2025 | 15.25 Mn |
| Mar 31, 2025 | 17.29 Mn |
| Dec 31, 2024 | 21.36 Mn |
| Sep 30, 2024 | 26.53 Mn |
| Jun 30, 2024 | 30.88 Mn |
| Mar 31, 2024 | 34.82 Mn |
| Dec 31, 2023 | 40.91 Mn |
| Sep 30, 2023 | 46.90 Mn |
| Jun 30, 2023 | 51.80 Mn |
| Mar 31, 2023 | 35.98 Mn |
| Dec 31, 2022 | 36.09 Mn |
| Sep 30, 2022 | 40.22 Mn |
| Jun 30, 2022 | 49.75 Mn |
| Mar 31, 2022 | 54.95 Mn |
| Dec 31, 2021 | 60.76 Mn |
| Sep 30, 2021 | 65.59 Mn |
API Access
Minerva Neurosciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();